XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Schedule of Stock Option Activity (Details) - 2017 Equity Plan and 2021 Equity Plan [Member]
9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Employees And Consultants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Granted 53,960
Employees And Consultants [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 158,174
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 10.99
Weighted Average Remaining Contractual Term, Beginning 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted 53,960
Weighted Average Exercise Price, Granted | $ / shares $ 2.90
Weighted Average Remaining Contractual Term, Granted 9 years 6 months
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled (15,235)
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares $ 8.58
Weighted Average Remaining Contractual Term, Forfeited 9 years 3 months 18 days
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 196,899
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 8.95
Weighted Average Remaining Contractual Term, Outstanding Ending 7 years 10 months 24 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 149,719
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 9.92
Weighted Average Remaining Contractual Term, Exercisable Ending 7 years 6 months
Aggregate Intrinsic Value, Exercisable Ending | $
Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Granted 6,250
Directors [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 50,872
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 10.02
Weighted Average Remaining Contractual Term, Beginning 6 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted 6,250
Weighted Average Exercise Price, Granted | $ / shares $ 4.80
Weighted Average Remaining Contractual Term, Granted 9 years 3 months 18 days
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 57,122
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Outstanding Ending 6 years 2 months 12 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 57,122
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Exercisable Ending 6 years 2 months 12 days
Aggregate Intrinsic Value, Exercisable Ending | $